Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

NS 2028

Name NS 2028
Supplier R&D Systems
Catalog 4517
Prices $189.00, $765.00
Sizes 10 mg, 50 mg
Cas Number 204326-43-2
Chemical Name 8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one
Formula C9H5BrN2O3
Molecular Weight 269.05
Purity >98%
Supplier Page Shop

Product References

Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of - Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of

von Wantoch Rekowski M, Pyriochou A, Papapetropoulos N, Stossel A, Papapetropoulos A, Giannis A. Bioorg Med Chem. 2010 Feb;18(3):1288-96.

The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial - The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial

Morbidelli L, Pyriochou A, Filippi S, Vasileiadis I, Roussos C, Zhou Z, Loutrari H, Waltenberger J, Stossel A, Giannis A, Ziche M, Papapetropoulos A. Am J Physiol Regul Integr Comp Physiol. 2010 Mar;298(3):R824-32. doi:

Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. - Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.

Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mulsch A. Br J Pharmacol. 1998 Jan;123(2):299-309.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved